Kevzara® (sarilumab) – New drug approval
May 22, 2017 – Regeneron and Sanofi announced the approval and availability of Kevzara (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).
Top